Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers

BACKGROUND: Venous thromboembolism (VTE) is a complex disease with an incidence rate of about 1 in 1000 per year. Despite the availability of validated biomarkers for VTE, unprovoked events account for 50% of first events. Therefore, emerging high‐throughput proteomics are promising methods for the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Pract Thromb Haemost
Autors principals: Faquih, Tariq, Mook‐Kanamori, Dennis O., Rosendaal, Frits R., Baglin, Trevor, Willems van Dijk, Ko, van Hylckama Vlieg, Astrid
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8110437/
https://ncbi.nlm.nih.gov/pubmed/34013156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12526
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars